Bay Harbor Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
31
+10
+48% +$3.71K ﹤0.01% 257
2026
Q1
$6.15K Buy
21
+6
+40% +$1.97K ﹤0.01% 306
2025
Q4
$5.26K Buy
15
+13
+650% +$4.39K ﹤0.01% 282
2025
Q3
$646 Sell
2
-12
-86% -$3.73K ﹤0.01% 634
2025
Q2
$5.45K Buy
14
+6
+75% +$2.41K ﹤0.01% 175
2025
Q1
$3.48K Hold
8
﹤0.01% 155
2024
Q4
$2.95K Buy
8
+3
+60% +$1.25K ﹤0.01% 146
2024
Q3
$2.6K Hold
5
﹤0.01% 143
2024
Q2
$2.71K Hold
5
﹤0.01% 138
2024
Q1
$2.59K Hold
5
﹤0.01% 146
2023
Q4
$2.36K Sell
5
-150
-97% -$69.4K ﹤0.01% 145
2023
Q3
$67.5K Buy
155
+4
+3% +$1.81K 0.03% 74
2023
Q2
$67.1K Sell
151
-12
-7% -$5.54K 0.03% 77
2023
Q1
$74.9K Buy
+163
New +$77.6K 0.03% 73
2021
Q1
Sell
-8
Closed -$3K 275
2020
Q4
$3K Buy
+8
New +$2.46K ﹤0.01% 312

Other funds holding ELV

Bay Harbor Wealth Management's ELV Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Elevance Health (ELV) stake by 48% in Q2 2026, buying an estimated $3.71K and bringing the position to 31 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Bay Harbor Wealth Management first reported a position in ELV in Q4 2020 and has held it in 15 quarters since. The position peaked at $74.9K in Q1 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bay Harbor Wealth Management held 31 shares of Elevance Health worth $12K as of Q2 2026.
  • Bay Harbor Wealth Management bought 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
  • Elevance Health made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #257 holding.
  • Bay Harbor Wealth Management first reported a position in Elevance Health in Q4 2020 and has held it in 15 quarters since.
  • Bay Harbor Wealth Management's Elevance Health position peaked at $74.9K in Q1 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.